FDA cleared the iGPS Navigation Instruments from SI-BONE, Inc. on Sep 15, 2025 under K251780, a traditional 510(k). The device falls under product code OLO, Orthopedic Stereotaxic Instrument, regulated at 21 CFR 882.4560 as a Class 2 device. The review panel was Neurology.

FDA logged the submission as received on Jun 10, 2025. The decision came 97 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

SI-BONE, Inc. has 2 other decisions in the tracker over the last 12 months: K253488 (iFuse INTRA Ti™ Implant System), K253094 (iFuse Bedrock Granite Implant System).